1) vinleurosine
长春罗辛
2) Vindesine
长春地辛
1.
The combination effectiveness of thrombin,lyophized nocardiarubra-cell wall skeleton,vindesine and cisplatine on patients with bloody malignant pleural effusion;
凝血酶联合胞必佳、长春地辛与顺铂治疗血性恶性胸腔积液疗效分析
2.
Objective To evaluate the clinical efficacy and toxicity of the two chemotherapeutic regimens GP (gemcitabine and cisplatin ) and IVP (isofosfamide, vindesine and cisplatin ) in advanced non-small cell lung cancer (NSCLC).
目的 比较化疗方案GP(吉西他滨和顺铂)和IVP(异环磷酰胺、长春地辛和顺铂)治疗晚期非小细胞肺癌(NSCLC)的疗效和毒性。
3.
OBJECTIVE To observe the efficacy and toxicity of vindesine(VDS),pirarubicin(THP),cyclophosphamide(CTX) and dexamethasone(DXM) combination therapy for non-Hodgkin s lymphoma.
目的观察应用长春地辛(VDS)、吡柔比星(THP)、环磷酰胺(CTX)、地塞米松(DXM)联合治疗非霍奇金淋巴瘤的疗效及不良反应。
3) VDS
长春地辛
1.
A Combined Therapy of Small-cell Lung Cancer Mainly with IFO DDP and VDS;
以异环磷酰胺、顺铂、长春地辛联合化疗为主综合治疗小细胞肺癌的疗效观察
2.
Clinical Comparison the Expressions of NVB and VDS Combined Regimens in the Treatment of 72 Cases of Advanced NSCLC;
异长春花碱,长春地辛联合方案治疗72例晚期非小细胞肺癌的临床对比研究
4) vinrosidine
长春罗定
5) Vinleurosine
长春罗新
6) vindesine sulfate
硫酸长春地辛
1.
A new method for the analysis of related substances in vindesine sulfate and its injection to improve the ability of separation by RP HPLC was established.
以反相高效液相色谱法检测硫酸长春地辛及其注射剂中的有关杂质。
补充资料：长春地辛
分子式：C43H55N5O7
分子量：暂无
CAS号：53643-48-4
性质：暂无
制备方法：暂无
用途：抗癌药。
分子量：暂无
CAS号：53643-48-4
性质：暂无
制备方法：暂无
用途：抗癌药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条